A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer

作者：Bolin Chen, Wenxiu Yao, Xingya Li, Gen Lin, Qian Chu, Hailong Liu, Yingying Du, Jie Lin, Huaxin Duan, Huijuan Wang, Zemin Xiao, Hong Sun, Liyu Liu, Li Xu, Yan Xu, Fang Xu, Yi Kong, Xingxiang Pu, Kang Li, Qianzhi Wang, Jia Li, Baiyong Li, Yu Xia, Lin Wu · 发表于：British Journal of Cancer · 年份：2023 · DOI：10.1038/s41416-023-02519-0 · 被引用次数：40 · 研究领域：Lung Cancer Research Studies、Cancer Immunotherapy and Biomarkers、Peptidase Inhibition and Analysis